Annual CAPEX
$56.00 K
-$488.90 K-89.72%
31 December 2023
Summary:
Silence Therapeutics annual capital expenditures is currently $56.00 thousand, with the most recent change of -$488.90 thousand (-89.72%) on 31 December 2023. During the last 3 years, it has fallen by -$603.70 thousand (-91.51%). SLN annual CAPEX is now -96.95% below its all-time high of $1.84 million, reached on 31 December 2021.SLN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$66.40 K
-$18.10 K-21.42%
01 September 2024
Summary:
Silence Therapeutics quarterly capital expenditures is currently $66.40 thousand, with the most recent change of -$18.10 thousand (-21.42%) on 01 September 2024. Over the past year, it has increased by +$40.70 thousand (+158.37%). SLN quarterly CAPEX is now -91.20% below its all-time high of $754.30 thousand, reached on 31 December 2021.SLN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$151.20 K
+$40.70 K+36.83%
01 September 2024
Summary:
Silence Therapeutics TTM capital expenditures is currently $151.20 thousand, with the most recent change of +$40.70 thousand (+36.83%) on 01 September 2024. Over the past year, it has dropped by -$288.10 thousand (-65.58%). SLN TTM CAPEX is now -91.76% below its all-time high of $1.84 million, reached on 31 December 2021.SLN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.7% | +158.4% | -65.6% |
| 3 y3 years | -91.5% | -85.2% | -86.0% |
| 5 y5 years | -77.7% | - | - |
SLN CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -97.0% | at low | -91.2% | +757.4% | -91.8% | +170.0% |
| 5 y | 5 years | -97.0% | +387.0% | -91.2% | +757.4% | -91.8% | +683.4% |
| alltime | all time | -97.0% | +761.5% | -91.2% | +757.4% | -91.8% | +683.4% |
Silence Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $66.40 K(-21.4%) | $151.20 K(+36.8%) |
| June 2024 | - | $84.50 K(>+9900.0%) | $110.50 K(+97.3%) |
| Dec 2023 | $56.00 K(-89.7%) | $300.00(-98.8%) | $56.00 K(-87.3%) |
| Sept 2023 | - | $25.70 K(-354.5%) | $439.30 K(-4.9%) |
| June 2023 | - | -$10.10 K(-125.2%) | $461.70 K(-21.1%) |
| Mar 2023 | - | $40.10 K(-89.5%) | $584.90 K(+7.4%) |
| Dec 2022 | $544.90 K(-70.3%) | $383.60 K(+697.5%) | $544.80 K(-40.5%) |
| Sept 2022 | - | $48.10 K(-57.5%) | $915.50 K(-30.4%) |
| June 2022 | - | $113.10 K(-85.0%) | $1.32 M(-28.3%) |
| Dec 2021 | $1.84 M(+178.2%) | $754.30 K(+68.4%) | $1.84 M(+69.8%) |
| Sept 2021 | - | $447.80 K(-27.1%) | $1.08 M(+70.7%) |
| June 2021 | - | $613.90 K(+3080.8%) | $633.20 K(+3180.8%) |
| Mar 2021 | - | $19.30 K | $19.30 K |
| Dec 2020 | $659.70 K(+5636.5%) | - | - |
| Dec 2019 | $11.50 K(-95.4%) | - | - |
| Dec 2018 | $250.80 K(+12.3%) | - | - |
| Dec 2017 | $223.40 K(-69.3%) | - | - |
| Dec 2016 | $727.60 K(-44.0%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $1.30 M(+133.1%) | - | - |
| Dec 2014 | $557.20 K(+158.1%) | - | - |
| Dec 2013 | $215.90 K(-32.6%) | - | - |
| Dec 2012 | $320.10 K(-27.4%) | - | - |
| Dec 2011 | $441.00 K(-2.4%) | - | - |
| Dec 2010 | $451.70 K(+28.2%) | - | - |
| Dec 2009 | $352.40 K(-29.9%) | - | - |
| Dec 2008 | $503.00 K(-52.7%) | - | - |
| Dec 2007 | $1.06 M(+343.3%) | - | - |
| Dec 2006 | $239.70 K(+56.9%) | - | - |
| Dec 2005 | $152.80 K(+339.1%) | - | - |
| Dec 2004 | $34.80 K(-31.4%) | - | - |
| Dec 2003 | $50.70 K(-54.4%) | - | - |
| Dec 2002 | $111.20 K(+1193.0%) | - | - |
| Dec 2001 | $8600.00(-95.1%) | - | - |
| Dec 2000 | $175.80 K(+2604.6%) | - | - |
| Dec 1999 | $6500.00(-21.7%) | - | - |
| Dec 1998 | $8300.00 | - | - |
FAQ
- What is Silence Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Silence Therapeutics?
- What is Silence Therapeutics annual CAPEX year-on-year change?
- What is Silence Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Silence Therapeutics?
- What is Silence Therapeutics quarterly CAPEX year-on-year change?
- What is Silence Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Silence Therapeutics?
- What is Silence Therapeutics TTM CAPEX year-on-year change?
What is Silence Therapeutics annual capital expenditures?
The current annual CAPEX of SLN is $56.00 K
What is the all time high annual CAPEX for Silence Therapeutics?
Silence Therapeutics all-time high annual capital expenditures is $1.84 M
What is Silence Therapeutics annual CAPEX year-on-year change?
Over the past year, SLN annual capital expenditures has changed by -$488.90 K (-89.72%)
What is Silence Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of SLN is $66.40 K
What is the all time high quarterly CAPEX for Silence Therapeutics?
Silence Therapeutics all-time high quarterly capital expenditures is $754.30 K
What is Silence Therapeutics quarterly CAPEX year-on-year change?
Over the past year, SLN quarterly capital expenditures has changed by +$40.70 K (+158.37%)
What is Silence Therapeutics TTM capital expenditures?
The current TTM CAPEX of SLN is $151.20 K
What is the all time high TTM CAPEX for Silence Therapeutics?
Silence Therapeutics all-time high TTM capital expenditures is $1.84 M
What is Silence Therapeutics TTM CAPEX year-on-year change?
Over the past year, SLN TTM capital expenditures has changed by -$288.10 K (-65.58%)